BOSTON--(BUSINESS WIRE)--Invest Australia, the Australian Government’s inward investment agency said at the Stem Cell Summit today that the Australian model of a unified and nationally backed stem cell research approach supported rapid commercialization and potential therapeutics for patients in the areas of haematology and cardiac and respiratory diseases.
